Characterization of Viral Glycopeptides and Support of Global SARS-CoV-2 Efforts
This year, Boston University's Professor Jospeh Zaia saw his group's focus pivot from Influenza A to SAR-CoV-2 in support of global COVID-19 efforts.
This webinar will highlight the challenges of viral glycosylation and its important role in vaccine development and efficacy as well as the assignment of site-specific glycosylations of the coronavirus spike protein.
What You Will Discover:
- Glycosylation and its importance in vaccine development
-Increased peak capacity from Ion Mobility Separation (IMS) and Collision Cross Section (CCS) can help in the site-specifc glycoform assignments
- How to support the informatics challenges of interpreting complex glycoproteomic data with GlycReSoft software.
Presenter: Professor Joseph Zaia, PhD (Professor of Biochemistry, Boston University)
Joseph has been a Professor of Biochemistry at Boston University since 1999. Prior to that, he worked as Research Technician for Harvard Medical School. He received his PhD from Massachusetts Institute of Technology in 1993.
